A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
type: MedicalStudy
description: A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
status: TERMINATED
study design: INTERVENTIONAL
phase: PHASE2
start date: 2009-03-11
end date: 2010-06-21
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00880048
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: GlaxoSmithKline
study subject: Depressive Disorder
keywords: PHASE2
keywords: INTERVENTIONAL
keywords: TERMINATED
keywords: Depressive Disorder

AI Analytics
type: Organization